World's first AI tool for prostate cancer monitoring available

With the update of mdprostate 1.3, the first fully automatic tool for identification and classification of lesions according to PI-RADS 2.1 with longitudinal evaluation is now available. Additionally, the performance of the tool has been significantly improved.

Longitudinal evaluation of MRI images is an essential component of reliable monitoring of prostate cancer. The latest version of mdprostate now offers, as the first AI tool, the possibility for automated comparison with the results of previous examinations. The clear tabular visualization enables a quick assessment of the lesion dynamics based on the changes in volume and expansion. In addition, the prostate volume is shown for both examinations and the PSA density can optionally be calculated. In this way, mdprostate offers optimal support for modern active surveillance.

 

Improved accuracy enables significant time savings

By expanding the training data and receiving active feedback from our radiology community, we were also able to significantly improve the accuracy of the tool once again. As a result, adjustments rarely need to be made to the fully automatically generated report, including the lesion diagram.

"mdprostate is intended to support radiologists by automating time-consuming processes and improving the objectivity of diagnosis through data quantification," explains Tonia Michaely, Director of Product Management at mediaire.


Experience the benefits of mdprostate live now

We offer a free and non-binding product demo to all interested parties conducted via video call by our product specialist and radiological expert, Marco Le Donne. Subsequently, an uncomplicated and free test via our browser-based Online-Demo is possible. Do not hesitate and book an appointment with us today.

Solutions

mediaire GmbH

Möckernstrasse 63
10965 Berlin, Germany

P +49 30 286 490 67
F +49 30 286 490 66

© 2025 mediaire GmbH

WORLD PREMIERE AT THE RÖKO 2024 IN GERMANY

Experience mdprostate, the first fully-automated AI-tool including longitudinal assessment for the evaluation of prostate MRIs.

mediaire GmbH

Möckernstrasse 63
10965 Berlin, Germany

P +49 30 286 490 67
F +49 30 286 490 66

© 2022 mediaire GmbH